Intuitive Surgical Upgraded by Raymond James to Outperform (ISRG)
A number of other firms have also recently commented on ISRG. Analysts at Zacks reiterated a “neutral” rating on shares of Intuitive Surgical in a research note on Monday, July 14th. They now have a $409.00 price target on the stock. Separately, analysts at ISI Group cut their price target on shares of Intuitive Surgical from $515.00 to $505.00 in a research note on Wednesday, July 9th. Finally, analysts at BTIG Research initiated coverage on shares of Intuitive Surgical in a research note on Tuesday, July 8th. They set a “neutral” rating on the stock. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and seven have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $443.56.
Shares of Intuitive Surgical (NASDAQ:ISRG) opened at 392.16 on Wednesday. Intuitive Surgical has a 52 week low of $346.46 and a 52 week high of $541.23. The stock’s 50-day moving average is $391.8 and its 200-day moving average is $408.. The company has a market cap of $15.060 billion and a P/E ratio of 29.19.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, July 22nd. The company reported $3.73 EPS for the quarter, beating the Thomson Reuters consensus estimate of $2.82 by $0.91. The company had revenue of $512.00 million for the quarter, compared to the consensus estimate of $502.23 million. During the same quarter in the prior year, the company posted $3.90 earnings per share. The company’s quarterly revenue was down 11.5% on a year-over-year basis. Analysts expect that Intuitive Surgical will post $11.81 EPS for the current fiscal year.
Intuitive Surgical, Inc (NASDAQ:ISRG) designs, manufactures and markets da Vinci Surgical Systems and related instruments and accessories.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.